A PYMNTS Company

US: Pfizer gets DOJ subpoenas amid saline antitrust investigation

By  |  April 19, 2017

Pfizer has received grand jury subpoenas from the US Justice Department as part of its antitrust investigation into the saline market, the company announced Wednesday.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The DOJ is seeking documents regarding the manufacturing, selling, pricing and shortages of intravenous solutions, including saline, as well as Pfizer’s communication with competitors. The subpoenas came one day after ICU Medical, which acquired Pfizer’s global infusion therapy business Hospira Infusion Systems in February, disclosed via Securities and Exchange Commission filings that it received a similar subpoena regarding IV solutions.

    Pfizer said in a statement that it will evaluate the Justice Department’s requests. “Pfizer can confirm that it has received grand jury subpoenas in connection with an investigation by the US Department of Justice, Antitrust Division and we are evaluating the requests,” Pfizer said.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.